Comparison of fibrosing mediastinitis patients with vs. without markedly increased systolic pulmonary arterial pressure: a single-center retrospective study

Fibrosing mediastinitis (FM) complicated with pulmonary hypertension (PH) has been considered as an important cause of morbidity and mortality. This study was designed to observe the possible effects of abnormal hemodynamics on patients by conducting a between-group comparison according to the prese...

Full description

Saved in:
Bibliographic Details
Published in:BMC cardiovascular disorders 2022-03, Vol.22 (1), p.134-134, Article 134
Main Authors: Zhang, Xinyuan, Zhang, Shu, Wang, Jianfeng, Jiang, Wei, Sun, Lanlan, Li, Yuanzhi, Guo, Dichen, Yang, Yuanhua, Lu, Xiuzhang, Li, Yidan
Format: Article
Language:English
Subjects:
Analysis
Angiography
Angioplasty
Arterial Pressure
Balloon pulmonary angioplasty
Balloon treatment
Blood pressure
Catheters
Complications and side effects
Computed tomography
CT imaging
Diseases
Echocardiography
Fibrosing mediastinitis
Heart
Hemodynamics
Humans
Mediastinitis
Mediastinitis - diagnostic imaging
Mediastinitis - therapy
Mediastinum
Methods
Morbidity
Patients
Pleural effusion
Prevention
Pulmonary arteries
Pulmonary fibrosis
Pulmonary hypertension
Radiation therapy
Regurgitation
Retrospective cohort
Retrospective Studies
Risk factors
Sclerosis
Structure-function relationships
Systole
Tomography
Tuberculosis
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fibrosing mediastinitis (FM) complicated with pulmonary hypertension (PH) has been considered as an important cause of morbidity and mortality. This study was designed to observe the possible effects of abnormal hemodynamics on patients by conducting a between-group comparison according to the presence of markedly increased systolic pulmonary arterial pressure (SPAP), so as to provide more information for clinical management. Fifty-one patients with clinically diagnosed FM were divided in two groups (SPAP 
ISSN:1471-2261
1471-2261
DOI:10.1186/s12872-022-02567-z